Oregon to receive $4.2 million in Risperdal illegal marketing settlemen
From The Oregonian, August 30, 2012 Oregon will receive more than $4.2 million under a multi-state settlement over alleged illegal marketing of the anti-psychotic drug Risperdal. The consumer protection settlement announced this morning is based on a long-running investigation into whether Janssen Pharmaceuticals, Inc, a subsidiary of Johnson & Johnson, paid kickbacks to providers to […]